Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.
Conditions: Hepatic Osteodystrophy; Liver Cirrhosis Interventions: Drug: Ibandronate; Drug: Calcium; Drug: Vitamin D3 Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
Condition: Edema Due to Heart Failure or Cirrhosis Intervention: Drug: Spironolactone Oral Suspension Sponsor: CMP Development, LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.
Conditions: Hepatic Osteodystrophy; Liver Cirrhosis Interventions: Drug: Ibandronate; Drug: Calcium; Drug: Vitamin D3 Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
Condition: Edema Due to Heart Failure or Cirrhosis Intervention: Drug: Spironolactone Oral Suspension Sponsor: CMP Development, LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.
Conditions: Hepatic Osteodystrophy; Liver Cirrhosis Interventions: Drug: Ibandronate; Drug: Calcium; Drug: Vitamin D3 Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
Condition: Edema Due to Heart Failure or Cirrhosis Intervention: Drug: Spironolactone Oral Suspension Sponsor: CMP Development, LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.
Conditions: Hepatic Osteodystrophy; Liver Cirrhosis Interventions: Drug: Ibandronate; Drug: Calcium; Drug: Vitamin D3 Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
Condition: Edema Due to Heart Failure or Cirrhosis Intervention: Drug: Spironolactone Oral Suspension Sponsor: CMP Development, LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.
Conditions: Hepatic Osteodystrophy; Liver Cirrhosis Interventions: Drug: Ibandronate; Drug: Calcium; Drug: Vitamin D3 Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
Condition: Edema Due to Heart Failure or Cirrhosis Intervention: Drug: Spironolactone Oral Suspension Sponsor: CMP Development, LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.
Conditions: Hepatic Osteodystrophy; Liver Cirrhosis Interventions: Drug: Ibandronate; Drug: Calcium; Drug: Vitamin D3 Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
Condition: Edema Due to Heart Failure or Cirrhosis Intervention: Drug: Spironolactone Oral Suspension Sponsor: CMP Development, LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.
Conditions: Hepatic Osteodystrophy; Liver Cirrhosis Interventions: Drug: Ibandronate; Drug: Calcium; Drug: Vitamin D3 Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
Condition: Edema Due to Heart Failure or Cirrhosis Intervention: Drug: Spironolactone Oral Suspension Sponsor: CMP Development, LLC Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.
Conditions: Hepatic Osteodystrophy; Liver Cirrhosis Interventions: Drug: Ibandronate; Drug: Calcium; Drug: Vitamin D3 Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials
